Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK9 | P50750 | 6/20 | 0.35 |
| ▸ | BRD4 | O60885 | 5/20 | 0.35 |
| ▸ | JAK2 | O60674 | 6/20 | 0.34 |
| ▸ | JAK3 | P52333 | 4/20 | 0.34 |
| ▸ | CDK2 | P24941 | 3/20 | 0.34 |
| ▸ | CDK1 | P06493 | 1/20 | 0.34 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.34 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.34 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650620 | 0.91 | CDK2 (0.36) | CDK9BRD4JAK2JAK3CDK2 | |
| SCHEMBL22650532 | 0.90 | EGFR (0.36) | CDK9BRD4EGFR | |
| SCHEMBL22650536 | 0.89 | JAK2 (0.34) | CDK9BRD4JAK2JAK3CDK2 | |
| SCHEMBL22650578 | 0.86 | IKBKB (0.35) | CDK9BRD4JAK2JAK3CDK2 | |
| SCHEMBL22650626 | 0.86 | CDK2 (0.39) | CDK9JAK2JAK3CDK2CDK1 | |
| SCHEMBL22650619 | 0.82 | CDK4 (0.40) | CDK9CDK2CDK1CCNB1CCNA2 | |
| SCHEMBL22650781 | 0.82 | IKBKB (0.39) | JAK2JAK3CDK2CDK1CCNB1 | |
| SCHEMBL22650777 | 0.81 | ACVR1 (0.35) | CDK9BRD4JAK2JAK3CDK2 | |
| SCHEMBL22650627 | 0.80 | CDK4 (0.39) | CDK9CDK2CDK1CCNB1CCNA2 | |
| SCHEMBL29491163 | 0.78 | CDK4 (0.46) | CDK9CDK2CDK1CCNB1CCNA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020224568-A1 | CDK INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2020-11-12 | — | — | WO | disclosed |